Moreover, we have also reported that vascular endothelial growth factor (VEGF) from cancer cells impairs activation and antigen presentation of Langerhans cell (LC) along with dysregulated T-cell activation in As-BD lesions [46]. This evidence concerns the gene VEGFA and Behcet disease.